Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
Sumrani
N
N
Department of Surgery, State University of New York Health Science Center at Brooklyn 11203, USA.
Hong
J
J
Miles
A
A
Markell
M
M
Distant
D
D
Fleishhacker
J
J
Maursky
V
V
Jean-Baptiste
F
F
Sommer
B
B
D000328:Adult; D000367:Age Factors; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood*; D016572:Cyclosporine / Q000627:therapeutic use; D005190:Family; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000628:therapy; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012189:Retrospective Studies; D012727:Sex Characteristics; D013997:Time Factors; D014019:Tissue Donors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone